TDG Gold Corp. (TSXV: TDG | OTCQX: TDGGF) (the “Company” or “TDG”) is pleased to report the remaining drilling results from the 2025 Phase I exploration program at the Aurora West Zone and Phase II ...
Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced its contribution to new research leveraging Multiplexed Assays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results